[28] Flow cytometric characterization of amyloid fibrils

Author(s):  
Jonathan Wall ◽  
Alan Solomon
2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Kiyoto Kamagata ◽  
Rika Chiba ◽  
Ichiro Kawahata ◽  
Nanako Iwaki ◽  
Saori Kanbayashi ◽  
...  

AbstractLiquid droplets of aggregation-prone proteins, which become hydrogels or form amyloid fibrils, are a potential target for drug discovery. In this study, we proposed an experiment-guided protocol for characterizing the design grammar of peptides that can regulate droplet formation and aggregation. The protocol essentially involves investigation of 19 amino acid additives and polymerization of the identified amino acids. As a proof of concept, we applied this protocol to fused in sarcoma (FUS). First, we evaluated 19 amino acid additives for an FUS solution and identified Arg and Tyr as suppressors of droplet formation. Molecular dynamics simulations suggested that the Arg additive interacts with specific residues of FUS, thereby inhibiting the cation–π and electrostatic interactions between the FUS molecules. Second, we observed that Arg polymers promote FUS droplet formation, unlike Arg monomers, by bridging the FUS molecules. Third, we found that the Arg additive suppressed solid aggregate formation of FUS, while Arg polymer enhanced it. Finally, we observed that amyloid-forming peptides induced the conversion of FUS droplets to solid aggregates of FUS. The developed protocol could be used for the primary design of peptides controlling liquid droplets and aggregates of proteins.


Cytotherapy ◽  
2002 ◽  
Vol 4 (1) ◽  
pp. 29-40 ◽  
Author(s):  
N. Hensel ◽  
J.J. Melenhorst ◽  
K. Bradstock ◽  
A.P. Schwarer ◽  
R. Eniafe ◽  
...  

2021 ◽  
Vol 22 (4) ◽  
pp. 1800
Author(s):  
Kun-Hua Yu ◽  
Mei-Yu Huang ◽  
Yi-Ru Lee ◽  
Yu-Kie Lin ◽  
Hau-Ren Chen ◽  
...  

Misfolding of prion protein (PrP) into amyloid aggregates is the central feature of prion diseases. PrP has an amyloidogenic C-terminal domain with three α-helices and a flexible tail in the N-terminal domain in which multiple octapeptide repeats are present in most mammals. The role of the octapeptides in prion diseases has previously been underestimated because the octapeptides are not located in the amyloidogenic domain. Correlation between the number of octapeptide repeats and age of onset suggests the critical role of octapeptide repeats in prion diseases. In this study, we have investigated four PrP variants without any octapeptides and with 1, 5 and 8 octapeptide repeats. From the comparison of the protein structure and the thermal stability of these proteins, as well as the characterization of amyloids converted from these PrP variants, we found that octapeptide repeats affect both folding and misfolding of PrP creating amyloid fibrils with distinct structures. Deletion of octapeptides forms fewer twisted fibrils and weakens the cytotoxicity. Insertion of octapeptides enhances the formation of typical silk-like fibrils but it does not increase the cytotoxicity. There might be some threshold effect and increasing the number of peptides beyond a certain limit has no further effect on the cell viability, though the reasons are unclear at this stage. Overall, the results of this study elucidate the molecular mechanism of octapeptides at the onset of prion diseases.


1992 ◽  
Vol 166 (1) ◽  
pp. 65-73 ◽  
Author(s):  
M. R. Yeaman ◽  
P. M. Sullam ◽  
P. F. Dazin ◽  
D. C. Norman ◽  
A. S. Bayer

Cytometry ◽  
2001 ◽  
Vol 45 (2) ◽  
pp. 102-114 ◽  
Author(s):  
Anna Waller ◽  
David Pipkorn ◽  
Karyn L. Sutton ◽  
Jennifer J. Linderman ◽  
Geneva M. Omann

2018 ◽  
Vol 161 ◽  
pp. 34-42 ◽  
Author(s):  
B. Miniscalco ◽  
A. Poggi ◽  
V. Martini ◽  
E. Morello ◽  
M. Sulce ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document